TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
ALVO

Alvotech

Healthcare · Drug Manufacturers - Specialty & Generic

5.90$ -3.7% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

Alvotech (ALVO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 106 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ALVO
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
18 53 37 199 103 151 133 173 114 166 106 106 492
37 56 20 45 40 80 65 74 35 61 46 52 195
-19 -3.0 17 154 63 71 67 99 79 105 60 54 297
53 58 50 48 34 40 38 55 52 40 25 22 138
17 18 15 14 17 15 19 27 26 20 26 44 115
70 76 65 62 50 57 57 81 78 57 50 65 250
-89 -79 -48 92 13 13 11 18 1.4 48 9.6 -12 47
44 69 184 42 91 159 36 37 36 41 41 41 159
-206 -309 -225 77 -25 -44 93 9.3 -6.0 40 1.0 -67 -32
-17 -32 -6.4 12 -13 23 -16 -23 -0.8 148 0.0 0.1 147
-188 -277 -219 65 -11 -67 110 32 -5.2 -109 1.0 -67 -180
-149 -234 -34 -17 138 -120 137 52 33 -85 52 -1.5 -1.4

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?